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Abstract We have studied the role of changes in mitochondrial
membrane potential (v8) in two widely-used models of
apoptosis, such as dexamethasone-treated rat thymocytes and
U937 human cells treated with tumor necrosis factor-K and
cycloheximide. To dissipate v8, we used low concentrations of
valinomycin, unable per se to induce apoptosis, and demonstrated
that the decline in v8 exerts opposite effects in the two models.
Indeed, in U937 cells, depolarization of mitochondria increased
apoptosis, which decreased in rat thymocytes. This leads to the
suggestion that disruption of v8 plays opposite roles depending
on the experimental model. In U937 cells, the drop of v8 is a
possible contributory cause for the apoptotic process; in rat
thymocytes, it could be a limiting factor. We propose that these
opposite effects could be due to the different ATP requirement of
each apoptotic pathway.
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1. Introduction
Mitochondria, the main cellular source of ATP, can play a
crucial role during apoptotic cell death, being involved in
several mechanisms, such as production of oxygen free radi-
cals [1,2], control of Ca2 ions [3], extrusion of apoptogenic
molecules such as cytochrome c (cyt c) [4], or the so called
apoptosis inducing factor [5]. As apoptosis is an active pro-
cess, it is reasonable that, at least during the earliest phases,
cells maintain a signi¢cant driving force for ATP synthesis
and, consequently, a high mitochondrial membrane potential
(v8). Indeed, using di¡erent experimental models, many au-
thors found no early alterations of v8 [6^9]. Moreover, the
ATP/ADP ratio is considered crucial for the decision of cell
fate [10,11], and it seems that when the ATP/ADP ratio falls
below the critical value of 0.2, cells undergo apoptosis [12].
Only when a severe drop of ATP occurs, apoptosis ceases and
ushers in necrosis. In this perspective, prolonged mitochon-
drial depolarization would cause necrotic cell death.
A new role has been proposed for mitochondria during the
induction of apoptosis : these organelles act as e¡ectors of the
central phase of apoptotic pathway, after which cells are irre-
versibly committed to die [13]. This suggests that the impair-
ment of mitochondrial function and the consequent collapse
in v8 represent the main stimulus for apoptosis to occur [14].
To give further insights into the role of mitochondria dur-
ing apoptosis, we analyzed v8 changes in two widely used
models : dexamethasone (DEX)-treated rat thymocytes or tu-
mor necrosis factor-K (TNF-K)-treated U937 human cells. Us-
ing low concentrations of valinomycin (Val) to dissipate v8
[15], we observed opposite e¡ects, as v8 collapse decreased
apoptosis in thymocytes but increased it in U937 cells.
2. Materials and methods
2.1. Cell cultures and experimental procedures
U937 cells were cultured in complete medium (RPMI 1640 with
10% heat-inactivated fetal calf serum, 2 mM L-glutamine, 100 IU/ml
penicillin, 100 Wg/ml streptomycin) and kept at 37‡C in a humidi¢ed
atmosphere (5% CO2 in air). Cells were collected during the log phase
of growth, washed in phosphate-bu¡ered saline (PBS), counted and
adjusted at a density of 200 000/ml in complete medium. Cells were
seeded in Petri dishes and kept at 37‡C in a humidi¢ed atmosphere
(5% CO2 in air) for di¡erent periods. Time-course (3, 8 and 24 h) and
dose-response experiments were performed using 100 nM, 1 WM and
10 WM Val (Sigma, St. Louis, MO, USA). In a further set of experi-
ments, U937 cells were pre-treated with 4 WM cycloheximide (CHX)
for 2 h and then with 50 IU/ml TNF-K for 6 h. In some experiments,
after 1 h of incubation with TNF-K, U937 cells were added with 1 WM
cyclosporin A (CsA, Sandoz, Basel, Switzerland).
Three week old Sprague^Dawley rats were killed by decapitation
and thymus was rapidly excised. Thymocytes were prepared by gently
pressing the organ against ¢ne stainless steel screens, counted and
adjusted at 5U106 cells/ml in complete medium; then were treated
with 100 nM DEX (Sigma) for 18 h in the presence or not of 100 nM
Val.
2.2. Flow cytometry
Cyto£uorometric analyses were performed using a FACScan (Bec-
ton Dickinson, San Jose¤, CA, USA), on a minimum of 10 000 cells per
sample. We assessed: (1) viability, by the propidium iodide (PI) ex-
clusion test. Cells were collected, resuspended in 400 Wl PBS, stained
with 5 Wg/ml PI and analyzed. Those with an intact plasma membrane
(viable or apoptotic, but not necrotic) were negative for PI; (2) early
0014-5793 / 00 / $20.00 ß 2000 Federation of European Biochemical Societies. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 0 ) 0 1 2 6 6 - 7
*Corresponding author. Fax: (39)-59-428 623.
E-mail: cossariz@unimo.it
Abbreviations: v8, mitochondrial membrane potential; JC-1,
5,5P,6,6P-tetrachloro-1,1P,3,3P-tetraethylbenzimidazolcarbocyanine io-
dide; Val, valinomycin; TNF-K, tumor necrosis factor-K ; PI, propi-
dium iodide; CsA, cyclosporin A; MPT, mitochondrial permeability
transition
FEBS 23408 2-3-00
FEBS 23408FEBS Letters 469 (2000) 186^190
apoptosis, by the exposure of phosphatidylserine, using FITC-conju-
gated annexin-V (ANX-V, Bender MedSystem, Wien, Austria).
Brie£y, 4U105 cells were resuspended in 200 Wl of binding bu¡er
(10 mM HEPES/NaOH pH 7.4, 140 mM NaCl, 2.5 mM CaCl2)
and incubated in the dark with 5 Wl of ANX-V for 10 min at room
temperature. Samples were washed with binding bu¡er, resuspended
in PBS, counterstained with 5 Wg/ml PI to identify dead cells and
analyzed; (3) late apoptosis, by the classic test of DNA hypodiploid
peak revealed by PI. Cells were resuspended in hypotonic solution
(0.1% sodium citrate, 0.1% Triton X-100 and 50 Wg/ml PI) and kept
for 30 min at 4‡C before the analysis; (4) v8, by the lipophilic cation
5,5P,6,6P-tetrachloro-1,1P,3,3P-tetraethylbenzimidazolcarbocyanine io-
dide (JC-1, Molecular Probes, Eugene, OR, USA) [15]. Cells were
stained with 2.5 Wg/ml JC-1 and kept at room temperature for
10 min, washed twice, resuspended in 400 Wl PBS and analyzed.
2.3. Confocal microscopy
To study the release of cyt c from mitochondria, U937 cells were
stained with 50 nM MitoTracker Red CMX-Ros (MT, Molecular
Probes) for the detection of v8 and incubated for 30 min at 37‡C.
Cells were then washed with cold PBS and ¢xed in 2% paraformalde-
hyde PBS, then permeabilized with ice-cold methanol. They were then
labeled with monoclonal antibody (mAb) against cyt c (Pharmingen,
San Diego, CA, USA) following standard procedures for intracellular
antigen staining, and spun down on a glass slide. Confocal analysis
was performed with a TCS 4D confocal microscope (Leica, Germany)
equipped with an argon laser and managed with Scanware software.
Images were obtained with a 63U magni¢cation and further enlarged
with an electronic zoom. Image analysis was performed using Con-
focal Assistant 4.02 (from Bio-Rad) and LView Pro 1.D2/32 software.
2.4. Western blot analysis
After 6 h of treatment, U937 cells were harvested and washed twice
in PBS and then resuspended in 80^140 Wl of RIPA bu¡er (Tris bu¡er
pH 8 50 mM, NaCl 150 mM, sodium deoxycholate 0.5%, sodium
dodecyl sulfate (SDS) 0.1%, Triton X-100 1%, EDTA 5 mM, PMSF
100 Wg/ml, leupeptin, aprotinin and pepstatin 5 Wg/ml) for protein
extraction. Protein concentration was determined according to Brad-
ford [16]. Protein extracts (40 Wg) were subjected to electrophoresis in
an SDS^polyacrylamide gel (8% for PARP, 12% for CPP32) and then
transferred onto a nitrocellulose paper by electrophoresis in a Trans-
blot chamber (Mini Protean II, Bio-Rad, Hercules, CA, USA). Pro-
teins were identi¢ed using mAbs against PARP (Biomol Laboratories,
Plymouth Meeting, PA, USA) and CPP32 (Transduction Laborato-
ries, Lexington, KY, USA) and ECL-Western reagents (Amersham
Corp.).
2.5. Intracellular ATP content determination
Cells were collected after 2 h of incubation, washed, counted and
resuspended at the concentration of 5U106/ml in distilled water. Cells
were then boiled for 1 min and spun down to eliminate membranes
and DNA. ATP was measured in the supernatant using ATP Bio-
luminescence Assay kit CLS II (Boehringer Mannheim, Germany)
and LKB 1250 Wallac luminometer (Finland).
2.6. Statistical analysis
Statistical analysis was performed using the paired Student’s t-test.
3. Results
3.1. Low doses of Val provoke a prolonged mitochondrial
depolarization but do not induce apoptosis, that was caused
by high doses of Val, unable however to activate caspases
To study the e¡ects of Val, we performed dose- and time-
response analyses (Fig. 1, upper part). U937 cells were treated
with increasing doses of Val for di¡erent periods of time, and
the dose of Val we used to depolarize mitochondria (100 nM
up to 1 WM) did not induce apoptosis per se even after 24 h of
incubation, as assessed by confocal microscopy (not shown)
and £ow cytometry. However, a 100-fold higher dose (10 WM)
induced cell death.
To ascertain whether such a proapoptotic e¡ect of high
doses of Val was caused by a direct action on ICE or other
ICE-related proteases, we investigated the activation of the
apoptosis-related caspase CPP32 and the degradation of a
typical substrate for proteases such as PARP. We studied
the cleavage of 32 kDa procaspase 3 and of 116 kDa PARP
to the 85 kDa form by Western blot analysis in U937 cells
(Fig. 1, lower part). Val was not able per se to induce CPP32
maturation and PARP cleavage, and the same was observed
for TNF-K or for CHX alone. On the contrary, TNF-K plus
CHX, and TNF-K plus CHX plus Val induced massive CPP32
maturation and PARP cleavage. Thus, an involvement of Val
on the induction/processing of such apoptosis-related proteins
can be excluded.
3.2. E¡ects of Val on apoptosis induced by TNF-K in U937
cells or by DEX in rat thymocytes
Table 1 reports the results concerning changes in v8, apop-
tosis and alteration of plasma membrane integrity in U937
cells or rat thymocytes. According to [17], CHX alone or
TNF-K alone did not induce a notable cell death (data not
shown). After 6 h of incubation, the percentage of apoptotic
cells was signi¢cantly lower in samples treated with TNF-K
plus CHX (26.5%) with respect to those treated also with 100
nM Val (42.8%, P6 0.01). Consequently, an increase in the
percentage of cells undergone secondary necrosis (permeant to
PI) occurred. Since Val alone did not induce apoptosis (like
TNF-K alone), we checked whether a possible synergistic ef-
fect of CHX and Val could exist, but together they were un-
able to induce apoptosis (not shown).
Concerning rat thymocytes, spontaneous v8 decrease and
appearance of apoptotic cells were present after 18 h of cul-
Fig. 1. Induction of apoptosis and caspase activity in Val-treated
U937 cells. Upper part: analysis of U937 cells after 8 h of culture
in the presence of di¡erent doses of Val. A dose-response study was
performed using doses of Val ranging from 100 nM to 10 WM. Only
the highest dose induces apoptosis. The histogram shows a typical
experiment out of ¢ve, indicating the percentage of apoptotic cells,
as assessed by £ow cytometry after PI staining. Lower part: West-
ern blot shows procaspase 3 (CPP32) and PARP cleavage after 6 h
of incubation with the indicated substances.
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ture. Adding Val for such a period caused abundant cell
death, even if we used low doses (100 nM). Nevertheless,
for a shorter period of time (6 h), Val did not induce cell
death (not shown). When used in combination with DEX
for 18 h, Val partially decreased glucocorticoid-induced apop-
tosis. As reported [6], DEX induced a time-dependent increase
in the percentage of cells with low v8, reaching the same level
of Val after 18 h, i.e. only when a massive cell death is
present. We analyzed the e¡ect of a shorter exposure to Val
(6 h) measuring ANX-V binding. Our results con¢rmed that
Val protected thymocytes from apoptosis since the earliest
phases of such process. The percentage of control, untreated
cells that bound ANX-V was 5.2 þ 0.4 (mean þ S.E.M. of four
experiments), that of cells treated with Val alone 6.8 þ 0.6
(P = NS), that incubated with DEX 27.3 þ 1.8 (P6 0.01 vs.
control), that of cells incubated with DEX and Val 8.0 þ 0.4
(P6 0.005 vs. DEX; P6 0.01 vs. control).
3.3. E¡ects of Val on cyt c release
We tested the possibility that v8 collapse provoked a re-
lease of cyt c in the cytoplasm from the mitochondrial inter-
membrane space. Fig. 2 shows confocal analysis of U937 cells
labeled with anti-cyt c mAbs (upper panels) and counter-
stained with MT, used to identify mitochondria (lower pan-
els). Left panels show control, untreated cells, in which £uo-
rescences from anti-cyt c mAb and from mitochondria display
the same distribution pattern. Central panels show U937 cells
after 4 h of Val treatment. Fluorescence from anti-cyt c mAb
is still well localized, while that from mitochondria is dropped,
indicating a fall in v8. Right panels show U937 cells after 3 h
of treatment with TNF-K plus CHX. Cyt c £uorescence is
widely spread in the cytoplasm of many cells, while that of
MT is partially dropped. This clearly suggests that depolari-
zation of mitochondria induced by Val per se does not pro-
voke cyt c e¥ux.
In parallel experiments, to functionally test the hypothesis
that TNF-K induces apoptosis by releasing cyt c, we tried to
block apoptosis using 1 WM CsA, but observed no e¡ect. In-
deed, apoptosis was 52.7 þ 1.3% in TNF-K plus CHX-treated
cultures, and 50.1 þ 4.5% in the presence of CsA (P = NS).
The di¡erence between the percentage of apoptotic cells re-
vealed by this method and that of PI staining (26.5%, Table 1)
was likely due to the fact that they analyze two di¡erent
phases of the apoptotic process.
3.4. Intracellular ATP content analysis
We ¢nally measured the intracellular ATP content in U937
Table 1
E¡ects of collapse in v8 on apoptosis in U937 cells or rat thymo-
cytes
Treatment Low v8 Apoptotic PI+
Control U937 3.4 þ 0.6 2.2 þ 0.3 1.0 þ 0.3
TNF-K+CHX 26.7 þ 2.3* 26.5 þ 2.3*# 9.4 þ 1.7*#
Val 73.7 þ 6.4*‡ 3.0 þ 0.5 1.3 þ 0.4
TNF-K+CHX+Val 82.7 þ 1.3*‡# 42.8 þ 5.4*‡# 17.9 þ 4.3*#
Control thymocytes 15.9 þ 1.4 14.6 þ 3.7 12.0 þ 2.4
DEX 86.9 þ 3.1* 90.2 þ 1.9* 48.1 þ 5.9*
Val 84.5 þ 3.7* 56.2 þ 3.6# 28.7 þ 5.8*3
DEX+Val 88.4 þ 2.4* 69.1 þ 2.8#^ 37.9 þ 4.8*Q
Data refer to the percentage of cells with low v8, apoptotic, and
with impaired membrane integrity (permeant to PI). Incubation was
6 h for U937 cells, 18 h for rat thymocytes. Data are expressed as
mean þ S.E.M. of six experiments.
Statistical analysis was performed using the paired Student’s t-test:
U937: P always 6 0.01, * = vs. control; ‡ = vs. TNF-K+CHX;
# = vs. Val.
Rat thymocytes: * = vs. control, P6 0.01;  = vs. control, P6 0.05;
# = vs. DEX, P6 0.01; 3= vs. DEX, P6 0.05; ^ = vs. Val, P6 0.01;
Q= vs. Val, P6 0.05.
Fig. 2. Confocal analysis of cyt c release. Upper panels: U937 cells stained with anti-cyt c mAb, as revealed by a FITC-conjugate secondary
antibody, showed a green £uorescence, which was collected by a 520 nm band-pass ¢lter. Lower panels: the same cells counterstained with a
v8-sensitive £uorescent probe, MT, showed a red £uorescence, related to v8, revealed by 599 nm band-pass ¢lter. All images have been trans-
formed in black and white using CAS software. Left panels: control, untreated cells. Central panels: cells treated with 100 nM Val. Right pan-
els: cells treated with TNF-K plus CHX. Note that the £uorescence is widely spread into the cytoplasm of some cells (arrows), and markedly
di¡erent from that of control or Val-treated cells. Also note that a marked decrease in v8 occurs only in cells treated with Val.
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cells and rat thymocytes after 2 h of incubation with TNF-K
plus CHX or with DEX, respectively, in the presence or ab-
sence of Val (Table 2). TNF-K plus CHX treatment caused a
signi¢cant decrease in ATP content in U937 cells, while DEX
did not exert a similar e¡ect in rat thymocytes. As expected,
Val caused a dramatic decrease of ATP content in both cell
types.
4. Discussion
We ¢rst investigated the role of v8 in causing apoptosis,
and, using di¡erent techniques, found that in U937 cells, mi-
tochondrial depolarization induced by low doses of the K
ionophore Val is per se not able to trigger apoptosis. Thus, in
these cells, the drop in v8 is not linked to the release of
apoptogenic compounds from mitochondria. This is in agree-
ment with recent data obtained in human osteosarcoma cells
that may undergo mitochondrial permeability transition
(MPT) and swelling in a reversible manner, without any
sign of cell death [18].
High doses of Val induce apoptosis in di¡erent cells [19,20].
Nevertheless, it is quite unlikely that this e¡ect could be due
to the v8-dissipating action of Val, since a dose capable of
collapsing v8 is unable to induce apoptosis in our model (i.e.
U937 cells). It is more likely that high doses of the ionophore
can induce apoptosis by non-speci¢c Ca2 release due to hy-
perpolarization of the plasma membrane [19], or by other
phenomena involving changes in ion osmolarity. It is note-
worthy that low doses of Val can induce cell death in cells
that are already programmed to die like rat thymocytes, but
only after a relatively long period of time (18 h). This phe-
nomenon could be due to the collapse of v8, which in turn
provokes a severe drop in ATP (whose levels were about 13%
of control cells, see Table 2), much marked than that observed
in U937 cells (about 30%).
TNF-K induces CPP32 activation in ML-1a cells, and this
activation requires mitochondrial respiratory functions [21].
On the contrary, we observed that TNF-K alone was unable
to activate CPP32 on U937 cells. Also CHX failed to activate
the protease cascade. This is in agreement with previous re-
ports [22], suggesting that the sensitizing e¡ect of CHX to
TNF-K is due to its ability to increase cyclin A-associated
kinase. Only when CHX and TNF-K are both present in the
same culture, the activation of CPP32 and PARP cleavage can
occur. We can reasonably exclude that Val increases TNF-K-
induced apoptosis by activating proteases, since in Val-treated
U937 cells, neither cleavage of PARP nor of CPP32 caspase
occurs. Even if the involvement of other ICE-like proteases
triggered by the depletion of cytoplasmic K is theoretically
possible, as already suggested [23], it is likely that the di¡erent
e¡ects of Val in the two models (i.e. increase or decrease of
apoptosis) should be due to its action on v8.
In thymocytes, glucocorticoid-induced apoptosis needs pro-
tein neosynthesis [24]. If energy is in some way dissipated, it is
likely that this form of death does not occur. Thus, if v8
decreases and ATP is no longer available for protein synthe-
sis, apoptosis could be inhibited, at least partially and until
the drop of ATP itself causes cell death. This is con¢rmed by
the analysis of ATP content, which showed no signi¢cant
changes after 2 h of culture with DEX in rat thymocytes.
This is in agreement with previous data showing no early
loss of ATP [25]. When Val was added, ATP decreased and
apoptosis was inhibited. On the other hand, in a di¡erent
system which does not need full energy supply, such as
TNF-K plus CHX-treated U937 cells [26], Val treatment and
the consequent disruption of v8 did not confer any protec-
tion. A rapid (2 h) ATP decrease was present in TNF-K plus
CHX-treated cells, although the v8 impairment occurred lat-
er (6 h). Since Val alone does not induce apoptosis, the fall of
ATP content should not be considered the cause, but rather a
consequence of the apoptotic process. Together with the data
on cyt c release, this indicates a possible mitochondrial in-
volvement in the absence of v8 fall during TNF-K-induced
apoptosis. Nevertheless, this death process seems not to be
inhibited by low doses of CsA. This suggests that the pathway
activated by TNF-K could by-pass the MPT step. However, it
is known that CsA has only a transient e¡ect on MPT [27],
and this could account for the loss of any protective e¡ect.
The use of a more stable inhibitor of MPT would clarify this
hypothesis.
In conclusion, our data suggest that at least two di¡erent
families of apoptotic pathways can exist, based on the sensi-
tivity to Val and thus to the collapse in v8 : the ¢rst in which
Val increases apoptosis, the second in which Val protects from
apoptosis. This leads to the suggestion that disruption of v8
plays opposite roles depending on the experimental model
which is used, e.g. signal transduction-induced apoptosis
(like in U937 cells) and programmed cell death (like in rat
thymocytes). In the ¢rst model, the drop of v8, and thus of
ATP, is a possible contributory cause for the apoptotic pro-
cess ; in the latter, it could be a limiting factor for apoptosis to
occur.
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